TScan Therapeutics TCRX
NASDAQ TCRX
$0.14 -0.01 (-6.67%)
At close: Nov 19, 2026 · 4:00 PM EST

TScan Therapeutics (TCRX) Common Equity (2020 - 2026)

Updated

TScan Therapeutics' Common Equity was $38.01 million in Q3 2026, down 73.6% from $144.02 million a year earlier and down 44.9% from the prior quarter.

Analysis

TScan Therapeutics (TCRX) Common Equity (2020 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at TScan Therapeutics came in at $123.12 million, down 48.9% from FY2024.

  • In earlier years, Common Equity was $240.97 million in FY2024 (+59.7%), $150.87 million in FY2023 (+51.7%), $99.43 million in FY2022 (-38.2%) and $160.78 million in FY2021.
  • The Q3 2026 figure marks the lowest quarterly Common Equity since Q2 2021.
  • Compared with a year earlier, Common Equity has declined for six straight quarters, with an average decline of 21.8% over the last eight quarters.
  • The best year-over-year quarter for Common Equity over five years was Q1 2025 (growth of 70.9%); the worst was Q3 2026 (a decline of 73.6%).
  • Per Business Quant data, TCRX's Common Equity in the three quarters before Q3 2026 was $69.02 million (Q2 2026), $96.92 million (Q1 2026) and $123.12 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Common Equity (Qtr)
1 PetVivo Holdings 3,096.39 Bn 3,096.39 Bn 196,075.00 -159,093.00
2 Eli Lilly 1,202.70 Bn 1,176.32 Bn 20.46 Bn 40.27 Bn
3 Johnson & Johnson 649.77 Bn 569.63 Bn 17.30 Bn 81.53 Bn
4 AbbVie 507.00 Bn 475.00 Bn 13.12 Bn -4.58 Bn
5 Merck 329.70 Bn 292.64 Bn 13.19 Bn 44.95 Bn
6 Novartis Ag 291.91 Bn 265.14 Bn - -
7 Amgen 236.26 Bn 187.91 Bn 7.58 Bn 14.35 Bn
8 Gilead Sciences 207.15 Bn 182.26 Bn 6.73 Bn 13.04 Bn
9 Gsk 193.54 Bn 176.38 Bn - 24.30 Bn
10 TScan Therapeutics 18.87 Mn -434.83 Mn - 38.01 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 38.01 Mn
Jun 30, 2026 69.02 Mn
Mar 31, 2026 96.92 Mn
Dec 31, 2025 123.12 Mn
Sep 30, 2025 144.02 Mn
Jun 30, 2025 176.71 Mn
Mar 31, 2025 210.20 Mn
Dec 31, 2024 240.97 Mn
Sep 30, 2024 229.09 Mn
Jun 30, 2024 255.22 Mn
Mar 31, 2024 122.97 Mn
Dec 31, 2023 150.87 Mn
Sep 30, 2023 168.96 Mn
Jun 30, 2023 190.61 Mn
Mar 31, 2023 78.02 Mn
Dec 31, 2022 99.43 Mn
Sep 30, 2022 116.66 Mn
Jun 30, 2022 131.65 Mn
Mar 31, 2022 145.69 Mn
Dec 31, 2021 160.78 Mn
API Access

TScan Therapeutics Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=TCRX&period=max&api_key=YOUR_API_KEY